A Case of Cobra Antivenom Therapy in a Patient Bitten by Elapid Snake in South Korea
10.22537/jksct.2022.20.1.22
- Author:
Ji Eun KIM
1
;
In Ho KWON
Author Information
1. Department of Emergency Medicine, College of Medicine, Dong-A University, Busan, Republic of Korea
- Publication Type:CASE REPORT
- From:Journal of The Korean Society of Clinical Toxicology
2022;20(1):22-24
- CountryRepublic of Korea
- Language:English
-
Abstract:
Elapid snakes have neurotoxic venom which causes diverse neuroparalytic manifestations, including fatal respiratory failure. In South Korea, since elapid snakebites are very rare, the cobra antivenom, which is effective against neurotoxicity, was only introduced recently. Most physicians in South Korea have little experience in the treatment of patients who have been bitten by elapid snakes. A 19-year-old man was brought to the emergency department with sudden diplopia, 1 hour after a snakebite on the left 2nd finger. The patient presented with drowsiness and complained of mild dizziness and binocular diplopia. After 1 hour, he had sudden onset of dyspnea and dysphagia and appeared to be agitated. He was immediately intubated and received mechanical ventilation as he was unable to breathe on his own. A total of 2.5 mg of neostigmine diluted with normal saline was slowly infused, and 1 vial of cobra antivenom was infused for an hour, 5 times every 2 hours, for a total of 5 vials. He slowly recovered self-breathing; on the 3rd day of hospitalization, he showed tolerable breathing and was extubated. He was discharged without any neurological deficits or other complications.
